Neuroglee Connect was developed in partnership with Mayo Clinic's HABIT Program with outcomes demonstrated in clinical studies published in Alzheimer's and Dementia.

The Neuroglee Connect solution is a patented, home-based technology program delivered in concert with a virtual physician-led interdisciplinary cognitive care team that improves patient and care partner outcomes across several domains including cognitive self-efficacy, depression, anxiety, stress, care partner burden and medical care plan compliance.

Neuroglee partners with primary care and neurology organizations to serve as a virtual extension of their practice helping them to accurately diagnose, but more importantly, provide rapid access to a solution for patients with MCI and early dementia to improve outcomes and reduced unncessary costs. We support patients at the 'entry point' of cognitive diease and serve as the long-term partner to the subset of patients who progress into more advanced forms of dementia.

The only evidenced-based, clinically proven solution that improves outcomes for patients with Mild Cognitive Impairment and early demential and their care partners.